_id
6919f1873c536f8df23185f1
Ticker
ABL.XETRA
Name
Abbott Laboratories
Exchange
XETRA
Address
100 Abbott Park Road, North Chicago, IL, United States, 60064-6400
Country
Germany
Sector
Healthcare
Industry
Medical Devices
Currency
EUR
Website
https://www.abbott.com
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Last Close
106.44
Volume
75
Current Price
108.34
Change
-0.48853814355505076
Last Updated
2025-12-30T11:52:20.308Z
Image
https://logo.clearbit.com/www.abbott.com
Ipo Date
-
Market Cap
187350106112
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
11369000000
Cost Of Revenue
5031000000
Gross Profit
6338000000
Operating Expenses
4308000000
Operating Income
2030000000
Interest Expense
44000000
Pretax Income
2180000000
Net Income
1644000000
Eps
0.9399656946826758
Dividends Per Share
1031000000
Shares Outstanding
1738871947
Income Tax Expense
536000000
EBITDA
3015000000
Operating Margin
17.85557216993579
Total Other Income Expense Net
150000000
Cash
7511000000
Short Term Investments
222000000
Receivables
10398000000
Inventories
6708000000
Total Current Assets
24839000000
Property Plant Equipment
11504000000
Total Assets
84181000000
Payables
4123000000
Short Term Debt
1345000000
Long Term Debt
11596000000
Total Liabilities
32917000000
Equity
50954000000
Bs_currency_symbol
USD
Depreciation
791000000
Change In Working Capital
11000000
Cash From Operations
2787000000
Capital Expenditures
496000000
Cash From Investing
-457000000
Cash From Financing
-1760000000
Net Change In Cash
560000000
Cf_currency_symbol
USD
PE
15.7456
PB
3.7187788986144366
ROE
3.22643953369706
ROA
1.9529347477459282
FCF
2291000000
Fcf Percent
0.20151288591784677
Piotroski FScore
4
Health Score
65
Deep Value Investing Score
5
Defensive Investing Score
6.5
Dividend Investing Score
3.5
Economic Moat Investing Score
7.3
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
7
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
11369000000
Quarters > 0 > income Statement > cost Of Revenue
5031000000
Quarters > 0 > income Statement > gross Profit
6338000000
Quarters > 0 > income Statement > operating Expenses
4308000000
Quarters > 0 > income Statement > operating Income
2030000000
Quarters > 0 > income Statement > interest Expense
44000000
Quarters > 0 > income Statement > pretax Income
2180000000
Quarters > 0 > income Statement > net Income
1644000000
Quarters > 0 > income Statement > eps
0.9399656946826758
Quarters > 0 > income Statement > dividends Per Share
1031000000
Quarters > 0 > income Statement > shares Outstanding
1749000000
Quarters > 0 > income Statement > income Tax Expense
536000000
Quarters > 0 > income Statement > EBITDA
3015000000
Quarters > 0 > income Statement > operating Margin
17.85557216993579
Quarters > 0 > income Statement > total Other Income Expense Net
150000000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
7511000000
Quarters > 0 > balance Sheet > short Term Investments
222000000
Quarters > 0 > balance Sheet > receivables
10398000000
Quarters > 0 > balance Sheet > inventories
6708000000
Quarters > 0 > balance Sheet > total Current Assets
24839000000
Quarters > 0 > balance Sheet > property Plant Equipment
11504000000
Quarters > 0 > balance Sheet > total Assets
84181000000
Quarters > 0 > balance Sheet > payables
4123000000
Quarters > 0 > balance Sheet > short Term Debt
1345000000
Quarters > 0 > balance Sheet > long Term Debt
11596000000
Quarters > 0 > balance Sheet > total Liabilities
32917000000
Quarters > 0 > balance Sheet > equity
50954000000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
1644000000
Quarters > 0 > cash Flow > depreciation
791000000
Quarters > 0 > cash Flow > change In Working Capital
11000000
Quarters > 0 > cash Flow > cash From Operations
2787000000
Quarters > 0 > cash Flow > capital Expenditures
496000000
Quarters > 0 > cash Flow > cash From Investing
-457000000
Quarters > 0 > cash Flow > cash From Financing
-1760000000
Quarters > 0 > cash Flow > net Change In Cash
560000000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
0.9399656946826758
Quarters > 0 > ratios > PB
3.7187788986144366
Quarters > 0 > ratios > ROE
3.22643953369706
Quarters > 0 > ratios > ROA
1.9529347477459282
Quarters > 0 > ratios > FCF
2291000000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.20151288591784677
Quarters > 0 > health Score
65
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
11142000000
Quarters > 1 > income Statement > cost Of Revenue
4854000000
Quarters > 1 > income Statement > gross Profit
6288000000
Quarters > 1 > income Statement > operating Expenses
4236000000
Quarters > 1 > income Statement > operating Income
2052000000
Quarters > 1 > income Statement > interest Expense
121000000
Quarters > 1 > income Statement > pretax Income
2150000000
Quarters > 1 > income Statement > net Income
1779000000
Quarters > 1 > income Statement > eps
1.0159908623643632
Quarters > 1 > income Statement > dividends Per Share
1029000000
Quarters > 1 > income Statement > shares Outstanding
1751000000
Quarters > 1 > income Statement > income Tax Expense
371000000
Quarters > 1 > income Statement > EBITDA
3048000000
Quarters > 1 > income Statement > operating Margin
18.416801292407108
Quarters > 1 > income Statement > total Other Income Expense Net
98000000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
6951000000
Quarters > 1 > balance Sheet > short Term Investments
331000000
Quarters > 1 > balance Sheet > receivables
10232000000
Quarters > 1 > balance Sheet > inventories
6954000000
Quarters > 1 > balance Sheet > total Current Assets
24468000000
Quarters > 1 > balance Sheet > property Plant Equipment
11395000000
Quarters > 1 > balance Sheet > total Assets
83999000000
Quarters > 1 > balance Sheet > payables
4306000000
Quarters > 1 > balance Sheet > short Term Debt
507000000
Quarters > 1 > balance Sheet > long Term Debt
12930000000
Quarters > 1 > balance Sheet > total Liabilities
33170000000
Quarters > 1 > balance Sheet > equity
50565000000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
1779000000
Quarters > 1 > cash Flow > depreciation
777000000
Quarters > 1 > cash Flow > change In Working Capital
-407000000
Quarters > 1 > cash Flow > cash From Operations
2047000000
Quarters > 1 > cash Flow > capital Expenditures
502000000
Quarters > 1 > cash Flow > cash From Investing
-582000000
Quarters > 1 > cash Flow > cash From Financing
-1097000000
Quarters > 1 > cash Flow > net Change In Cash
419000000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
1.0159908623643632
Quarters > 1 > ratios > PB
3.7516728962721255
Quarters > 1 > ratios > ROE
3.5182438445565114
Quarters > 1 > ratios > ROA
2.11788235574233
Quarters > 1 > ratios > FCF
1545000000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.1386645126548196
Quarters > 1 > health Score
59
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
10358000000
Quarters > 2 > income Statement > cost Of Revenue
4468000000
Quarters > 2 > income Statement > gross Profit
5890000000
Quarters > 2 > income Statement > operating Expenses
4197000000
Quarters > 2 > income Statement > operating Income
1693000000
Quarters > 2 > income Statement > interest Expense
131000000
Quarters > 2 > income Statement > pretax Income
1778000000
Quarters > 2 > income Statement > net Income
1325000000
Quarters > 2 > income Statement > eps
0.7584430452203778
Quarters > 2 > income Statement > dividends Per Share
1026000000
Quarters > 2 > income Statement > shares Outstanding
1747000000
Quarters > 2 > income Statement > income Tax Expense
453000000
Quarters > 2 > income Statement > EBITDA
2665000000
Quarters > 2 > income Statement > operating Margin
16.34485421896119
Quarters > 2 > income Statement > total Other Income Expense Net
85000000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
6037806000
Quarters > 2 > balance Sheet > short Term Investments
312000000
Quarters > 2 > balance Sheet > receivables
6772658000
Quarters > 2 > balance Sheet > inventories
6136710000
Quarters > 2 > balance Sheet > total Current Assets
21401303000
Quarters > 2 > balance Sheet > property Plant Equipment
10104913000
Quarters > 2 > balance Sheet > total Assets
75285853000
Quarters > 2 > balance Sheet > payables
3895180000
Quarters > 2 > balance Sheet > short Term Debt
467717000
Quarters > 2 > balance Sheet > long Term Debt
12736000000
Quarters > 2 > balance Sheet > total Liabilities
29933910000
Quarters > 2 > balance Sheet > equity
45118085000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
1325000000
Quarters > 2 > cash Flow > depreciation
756000000
Quarters > 2 > cash Flow > change In Working Capital
-517000000
Quarters > 2 > cash Flow > cash From Operations
1417000000
Quarters > 2 > cash Flow > capital Expenditures
484000000
Quarters > 2 > cash Flow > cash From Investing
-470000000
Quarters > 2 > cash Flow > cash From Financing
-2055000000
Quarters > 2 > cash Flow > net Change In Cash
-1084000000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.7584430452203778
Quarters > 2 > ratios > PB
4.194991431928017
Quarters > 2 > ratios > ROE
2.9367381173203606
Quarters > 2 > ratios > ROA
1.7599588066034133
Quarters > 2 > ratios > FCF
933000000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.09007530411276309
Quarters > 2 > health Score
53
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
10974000000
Quarters > 3 > income Statement > cost Of Revenue
4942000000
Quarters > 3 > income Statement > gross Profit
6032000000
Quarters > 3 > income Statement > operating Expenses
4121000000
Quarters > 3 > income Statement > operating Income
1911000000
Quarters > 3 > income Statement > interest Expense
136000000
Quarters > 3 > income Statement > pretax Income
2030000000
Quarters > 3 > income Statement > net Income
9229000000
Quarters > 3 > income Statement > eps
5.285796105383734
Quarters > 3 > income Statement > dividends Per Share
958000000
Quarters > 3 > income Statement > shares Outstanding
1746000000
Quarters > 3 > income Statement > income Tax Expense
-7199000000
Quarters > 3 > income Statement > EBITDA
2973000000
Quarters > 3 > income Statement > operating Margin
17.41388737014762
Quarters > 3 > income Statement > total Other Income Expense Net
119000000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
7616000000
Quarters > 3 > balance Sheet > short Term Investments
351000000
Quarters > 3 > balance Sheet > receivables
9495000000
Quarters > 3 > balance Sheet > inventories
6194000000
Quarters > 3 > balance Sheet > total Current Assets
23656000000
Quarters > 3 > balance Sheet > property Plant Equipment
10658000000
Quarters > 3 > balance Sheet > total Assets
81414000000
Quarters > 3 > balance Sheet > payables
4195000000
Quarters > 3 > balance Sheet > short Term Debt
1500000000
Quarters > 3 > balance Sheet > long Term Debt
12625000000
Quarters > 3 > balance Sheet > total Liabilities
33513000000
Quarters > 3 > balance Sheet > equity
47664000000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
9229000000
Quarters > 3 > cash Flow > depreciation
807000000
Quarters > 3 > cash Flow > change In Working Capital
-8391000000
Quarters > 3 > cash Flow > cash From Operations
2868000000
Quarters > 3 > cash Flow > capital Expenditures
720000000
Quarters > 3 > cash Flow > cash From Investing
-866000000
Quarters > 3 > cash Flow > cash From Financing
-1861000000
Quarters > 3 > cash Flow > net Change In Cash
58000000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
5.285796105383734
Quarters > 3 > ratios > PB
3.968648036253777
Quarters > 3 > ratios > ROE
19.362621685129238
Quarters > 3 > ratios > ROA
11.335888176480703
Quarters > 3 > ratios > FCF
2148000000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.1957353745215965
Quarters > 3 > health Score
83
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
41950000000
Annuals > 0 > income Statement > cost Of Revenue
18706000000
Annuals > 0 > income Statement > gross Profit
23244000000
Annuals > 0 > income Statement > operating Expenses
16419000000
Annuals > 0 > income Statement > operating Income
6825000000
Annuals > 0 > income Statement > interest Expense
559000000
Annuals > 0 > income Statement > pretax Income
7013000000
Annuals > 0 > income Statement > net Income
13402000000
Annuals > 0 > income Statement > eps
7.668816094328384
Annuals > 0 > income Statement > dividends Per Share
3836000000
Annuals > 0 > income Statement > shares Outstanding
1747597000
Annuals > 0 > income Statement > income Tax Expense
-6389000000
Annuals > 0 > income Statement > EBITDA
10790000000
Annuals > 0 > income Statement > operating Margin
16.269368295589988
Annuals > 0 > income Statement > total Other Income Expense Net
188000000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
7616000000
Annuals > 0 > balance Sheet > short Term Investments
351000000
Annuals > 0 > balance Sheet > receivables
9495000000
Annuals > 0 > balance Sheet > inventories
6194000000
Annuals > 0 > balance Sheet > total Current Assets
23656000000
Annuals > 0 > balance Sheet > property Plant Equipment
10658000000
Annuals > 0 > balance Sheet > total Assets
81414000000
Annuals > 0 > balance Sheet > payables
4195000000
Annuals > 0 > balance Sheet > short Term Debt
1754000000
Annuals > 0 > balance Sheet > long Term Debt
12625000000
Annuals > 0 > balance Sheet > total Liabilities
33513000000
Annuals > 0 > balance Sheet > equity
47664000000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
13402000000
Annuals > 0 > cash Flow > depreciation
3218000000
Annuals > 0 > cash Flow > change In Working Capital
-9217000000
Annuals > 0 > cash Flow > cash From Operations
8558000000
Annuals > 0 > cash Flow > capital Expenditures
2207000000
Annuals > 0 > cash Flow > cash From Investing
-2338000000
Annuals > 0 > cash Flow > cash From Financing
-5404000000
Annuals > 0 > cash Flow > net Change In Cash
720000000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
7.668816094328384
Annuals > 0 > ratios > PB
3.8908818739509905
Annuals > 0 > ratios > ROE
28.117656931856327
Annuals > 0 > ratios > ROA
16.46154224089223
Annuals > 0 > ratios > FCF
6351000000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.15139451728247913
Annuals > 0 > health Score
81
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
40109000000
Annuals > 1 > income Statement > cost Of Revenue
17919000000
Annuals > 1 > income Statement > gross Profit
22190000000
Annuals > 1 > income Statement > operating Expenses
15712000000
Annuals > 1 > income Statement > operating Income
6478000000
Annuals > 1 > income Statement > interest Expense
637000000
Annuals > 1 > income Statement > pretax Income
6664000000
Annuals > 1 > income Statement > net Income
5723000000
Annuals > 1 > income Statement > eps
3.272155517438536
Annuals > 1 > income Statement > dividends Per Share
3556000000
Annuals > 1 > income Statement > shares Outstanding
1749000000
Annuals > 1 > income Statement > income Tax Expense
941000000
Annuals > 1 > income Statement > EBITDA
10544000000
Annuals > 1 > income Statement > operating Margin
16.150988556184398
Annuals > 1 > income Statement > total Other Income Expense Net
186000000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
6896000000
Annuals > 1 > balance Sheet > short Term Investments
383000000
Annuals > 1 > balance Sheet > receivables
8821000000
Annuals > 1 > balance Sheet > inventories
6570000000
Annuals > 1 > balance Sheet > total Current Assets
22670000000
Annuals > 1 > balance Sheet > property Plant Equipment
11276000000
Annuals > 1 > balance Sheet > total Assets
73214000000
Annuals > 1 > balance Sheet > payables
4295000000
Annuals > 1 > balance Sheet > short Term Debt
1325000000
Annuals > 1 > balance Sheet > long Term Debt
13599000000
Annuals > 1 > balance Sheet > total Liabilities
34387000000
Annuals > 1 > balance Sheet > equity
38603000000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
5723000000
Annuals > 1 > cash Flow > depreciation
3243000000
Annuals > 1 > cash Flow > change In Working Capital
-2475000000
Annuals > 1 > cash Flow > cash From Operations
7261000000
Annuals > 1 > cash Flow > capital Expenditures
2202000000
Annuals > 1 > cash Flow > cash From Investing
-3133000000
Annuals > 1 > cash Flow > cash From Financing
-7091000000
Annuals > 1 > cash Flow > net Change In Cash
-2986000000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
3.272155517438536
Annuals > 1 > ratios > PB
4.8080169934979144
Annuals > 1 > ratios > ROE
14.825272647203585
Annuals > 1 > ratios > ROA
7.816810992433141
Annuals > 1 > ratios > FCF
5059000000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.12613129222867686
Annuals > 1 > health Score
72
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
43653000000
Annuals > 2 > income Statement > cost Of Revenue
19142000000
Annuals > 2 > income Statement > gross Profit
24511000000
Annuals > 2 > income Statement > operating Expenses
16149000000
Annuals > 2 > income Statement > operating Income
8362000000
Annuals > 2 > income Statement > interest Expense
558000000
Annuals > 2 > income Statement > pretax Income
8306000000
Annuals > 2 > income Statement > net Income
6933000000
Annuals > 2 > income Statement > eps
3.9302721088435373
Annuals > 2 > income Statement > dividends Per Share
3309000000
Annuals > 2 > income Statement > shares Outstanding
1764000000
Annuals > 2 > income Statement > income Tax Expense
1373000000
Annuals > 2 > income Statement > EBITDA
12131000000
Annuals > 2 > income Statement > operating Margin
19.155613588985865
Annuals > 2 > income Statement > total Other Income Expense Net
-56000000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
9882000000
Annuals > 2 > balance Sheet > short Term Investments
288000000
Annuals > 2 > balance Sheet > receivables
6218000000
Annuals > 2 > balance Sheet > inventories
6173000000
Annuals > 2 > balance Sheet > total Current Assets
25224000000
Annuals > 2 > balance Sheet > property Plant Equipment
9162000000
Annuals > 2 > balance Sheet > total Assets
74438000000
Annuals > 2 > balance Sheet > payables
4607000000
Annuals > 2 > balance Sheet > short Term Debt
2501000000
Annuals > 2 > balance Sheet > long Term Debt
14522000000
Annuals > 2 > balance Sheet > total Liabilities
37533000000
Annuals > 2 > balance Sheet > equity
36686000000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
6933000000
Annuals > 2 > cash Flow > depreciation
3267000000
Annuals > 2 > cash Flow > change In Working Capital
-1519000000
Annuals > 2 > cash Flow > cash From Operations
9581000000
Annuals > 2 > cash Flow > capital Expenditures
1777000000
Annuals > 2 > cash Flow > cash From Investing
-1740000000
Annuals > 2 > cash Flow > cash From Financing
-7636000000
Annuals > 2 > cash Flow > net Change In Cash
83000000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
3.9302721088435373
Annuals > 2 > ratios > PB
5.102646241072889
Annuals > 2 > ratios > ROE
18.898217303603555
Annuals > 2 > ratios > ROA
9.313791343131196
Annuals > 2 > ratios > FCF
7804000000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.1787735092662589
Annuals > 2 > health Score
76
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
43075000000
Annuals > 3 > income Statement > cost Of Revenue
18537000000
Annuals > 3 > income Statement > gross Profit
24538000000
Annuals > 3 > income Statement > operating Expenses
16113000000
Annuals > 3 > income Statement > operating Income
8425000000
Annuals > 3 > income Statement > interest Expense
533000000
Annuals > 3 > income Statement > pretax Income
8211000000
Annuals > 3 > income Statement > net Income
7071000000
Annuals > 3 > income Statement > eps
3.9524874231414198
Annuals > 3 > income Statement > dividends Per Share
3202000000
Annuals > 3 > income Statement > shares Outstanding
1789000000
Annuals > 3 > income Statement > income Tax Expense
1140000000
Annuals > 3 > income Statement > EBITDA
12282000000
Annuals > 3 > income Statement > operating Margin
19.55890887986071
Annuals > 3 > income Statement > total Other Income Expense Net
-214000000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
9799000000
Annuals > 3 > balance Sheet > short Term Investments
450000000
Annuals > 3 > balance Sheet > receivables
6487000000
Annuals > 3 > balance Sheet > inventories
5157000000
Annuals > 3 > balance Sheet > total Current Assets
24239000000
Annuals > 3 > balance Sheet > property Plant Equipment
8959000000
Annuals > 3 > balance Sheet > total Assets
75196000000
Annuals > 3 > balance Sheet > payables
4408000000
Annuals > 3 > balance Sheet > short Term Debt
999000000
Annuals > 3 > balance Sheet > long Term Debt
17296000000
Annuals > 3 > balance Sheet > total Liabilities
39172000000
Annuals > 3 > balance Sheet > equity
35802000000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
7071000000
Annuals > 3 > cash Flow > depreciation
3538000000
Annuals > 3 > cash Flow > change In Working Capital
-771000000
Annuals > 3 > cash Flow > cash From Operations
10533000000
Annuals > 3 > cash Flow > capital Expenditures
1885000000
Annuals > 3 > cash Flow > cash From Investing
-2008000000
Annuals > 3 > cash Flow > cash From Financing
-5494000000
Annuals > 3 > cash Flow > net Change In Cash
2961000000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
3.9524874231414198
Annuals > 3 > ratios > PB
5.30273951175912
Annuals > 3 > ratios > ROE
19.750293279705044
Annuals > 3 > ratios > ROA
9.40342571413373
Annuals > 3 > ratios > FCF
8648000000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.2007661056297156
Annuals > 3 > health Score
78
Valuation > metrics > PE
15.7456
Valuation > metrics > PB
3.7187788986144366
Valuation > final Score
72.81221101385563
Valuation > verdict
12.0% Overvalued
Profitability > metrics > ROE
3.22643953369706
Profitability > metrics > ROA
6.618623938161762
Profitability > metrics > Net Margin
0.1446037470314012
Profitability > final Score
48
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.64601405188994
Risk > metrics > Interest Coverage
46.13636363636363
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
4.542611558156548
Liquidity > metrics > Quick Ratio
3.315837600585223
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
62.48327103727874
Prev Valuations > 1
58.05008568071983
Prev Valuations > 2
60.313519637462235
Prev Profitabilities > 0
53
Prev Profitabilities > 1
44
Prev Profitabilities > 2
99
Prev Risks > 0
88
Prev Risks > 1
88
Prev Risks > 2
88
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:05:18.716Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-14
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-01-21
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
1.5
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-09-30
Earnings History > 2 > report Date
2025-10-15
Earnings History > 2 > date
2025-09-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.8044
Earnings History > 2 > eps Estimate
1.3
Earnings History > 2 > eps Difference
-0.4956
Earnings History > 2 > surprise Percent
-38.1231
Earnings History > 3 > period
2025-06-30
Earnings History > 3 > report Date
2025-07-17
Earnings History > 3 > date
2025-06-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
0.8957
Earnings History > 3 > eps Estimate
1.26
Earnings History > 3 > eps Difference
-0.3643
Earnings History > 3 > surprise Percent
-28.9127
Earnings History > 4 > period
2025-03-31
Earnings History > 4 > report Date
2025-04-16
Earnings History > 4 > date
2025-03-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
0.7206
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-12-31
Earnings History > 5 > report Date
2025-01-22
Earnings History > 5 > date
2024-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
4.9553
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-09-30
Earnings History > 6 > report Date
2024-10-16
Earnings History > 6 > date
2024-09-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
0.8572
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-06-30
Earnings History > 7 > report Date
2024-07-18
Earnings History > 7 > date
2024-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
0.6907
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2024-03-31
Earnings History > 8 > report Date
2024-04-17
Earnings History > 8 > date
2024-03-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
0.645
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-12-31
Earnings History > 9 > report Date
2024-01-24
Earnings History > 9 > date
2023-12-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0.8479
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-09-30
Earnings History > 10 > report Date
2023-10-18
Earnings History > 10 > date
2023-09-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
0.7552
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-06-30
Earnings History > 11 > report Date
2023-07-20
Earnings History > 11 > date
2023-06-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
0.7219
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2023-03-31
Earnings History > 12 > report Date
2023-04-19
Earnings History > 12 > date
2023-03-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
0.7011
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-12-31
Earnings History > 13 > report Date
2023-01-25
Earnings History > 13 > date
2022-12-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
0.5774
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-09-30
Earnings History > 14 > report Date
2022-10-19
Earnings History > 14 > date
2022-09-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
0.8081
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-06-30
Earnings History > 15 > report Date
2022-07-20
Earnings History > 15 > date
2022-06-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
1.0743
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2022-03-31
Earnings History > 16 > report Date
2022-04-20
Earnings History > 16 > date
2022-03-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
1.2289
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-12-31
Earnings History > 17 > report Date
2022-01-26
Earnings History > 17 > date
2021-12-31
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
0.9765
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-09-30
Earnings History > 18 > report Date
2021-10-20
Earnings History > 18 > date
2021-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
0.9959
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-06-30
Earnings History > 19 > report Date
2021-07-22
Earnings History > 19 > date
2021-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
0.55
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2021-03-31
Earnings History > 20 > report Date
2021-04-20
Earnings History > 20 > date
2021-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
0.8307
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-12-31
Earnings History > 21 > report Date
2021-01-27
Earnings History > 21 > date
2020-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
1.0085
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-09-30
Earnings History > 22 > report Date
2020-10-21
Earnings History > 22 > date
2020-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
0.5867
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-06-30
Earnings History > 23 > report Date
2020-07-16
Earnings History > 23 > date
2020-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
0.2716
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2020-03-31
Earnings History > 24 > report Date
2020-04-16
Earnings History > 24 > date
2020-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
0.286
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-12-31
Earnings History > 25 > report Date
2020-01-22
Earnings History > 25 > date
2019-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
0.5295
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Abbott Laboratories
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-12-31
EPS Actual
—
EPS Estimate
1.5
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-09-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.